Update: 11.03.2025
Last week: 9 week 2024 (24.02.2025 - 02.03.2025)
Last full month: February 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 445 | -0.5% | 12.1% | -1.1 | 20 103 216 | -2.5% | 8.8% | -1 | 8.2% |
| MoM | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| YTD | 75 344 | 26.8% | 12.7% | 1.6 | 158 886 968 | 19.1% | 9.3% | -0.3 | 10.5% |
| MAT | 437 355 | 23.4% | 12.6% | 3.1 | 864 541 603 | 22.1% | 9.3% | 1.2 | -6.9% |
| BRAINMAX | |||||||||
| WoW | 2 536 | 8.6% | 100.0% | 0 | 8 461 772 | 4.7% | 100.0% | 0 | 8.6% |
| MoM | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| YTD | 19 157 | 119.8% | 100.0% | 0 | 67 073 937 | 113.6% | 100.0% | 0 | 119.8% |
| MAT | 93 106 | 83.7% | 100.0% | 0 | 322 396 983 | 82.6% | 100.0% | 0 | 83.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 643 | 3.9% | 45.1% | -0.3 | 53 794 468 | 4.8% | 36.3% | 0 | 4.6% |
| MoM | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| YTD | 138 972 | -2.9% | 45.2% | 1.4 | 450 972 800 | -2.5% | 37.0% | 0.9 | -6.0% |
| MAT | 824 978 | -6.0% | 45.7% | 0.4 | 2 591 144 365 | -5.8% | 37.3% | -2.1 | -6.7% |
| MIGRENIUM | |||||||||
| WoW | 8 723 | 5.6% | 0.4% | 0 | 3 070 253 | 7.6% | 0.5% | 0 | 4.8% |
| MoM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| YTD | 73 156 | -32.3% | 0.4% | -0.2 | 25 418 441 | -14.5% | 0.5% | -0.1 | 1.6% |
| MAT | 532 895 | -17.2% | 0.5% | -0.1 | 177 343 379 | 33.1% | 0.6% | 0.1 | 0.5% |
| MODELAX-N | |||||||||
| WoW | 33 001 | -2.7% | 20.9% | -1.2 | 17 228 201 | -1.8% | 15.1% | -0.6 | 2.7% |
| MoM | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| YTD | 286 886 | 8.4% | 21.7% | 0 | 147 842 822 | 38.6% | 15.3% | 2.1 | 8.6% |
| MAT | 1 485 807 | 17.1% | 21.7% | 2.2 | 700 432 373 | 60.4% | 14.5% | 3.5 | 5.0% |
| REDUXIN | |||||||||
| WoW | 12 118 | 6.5% | 32.9% | 0.6 | 67 336 377 | 4.9% | 45.4% | 0 | 4.6% |
| MoM | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| YTD | 98 761 | -9.5% | 32.1% | -1.3 | 539 166 826 | -8.5% | 44.2% | -1.8 | -6.0% |
| MAT | 585 124 | -7.3% | 32.4% | -0.2 | 3 113 290 846 | 4.5% | 44.8% | 2.1 | -6.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 857 | 8.7% | 10.5% | 0.4 | 17 305 807 | 8.5% | 11.7% | 0.4 | 4.6% |
| MoM | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| YTD | 30 963 | 8.0% | 10.1% | 1.3 | 138 736 601 | 8.8% | 11.4% | 1.4 | -6.0% |
| MAT | 169 662 | 0.5% | 9.4% | 0.7 | 732 870 956 | 6.8% | 10.6% | 0.7 | -6.7% |
| SALVISAR | |||||||||
| WoW | 14 498 | -6.8% | 1.9% | -0.2 | 7 086 647 | -5.4% | 1.9% | -0.2 | 2.7% |
| MoM | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
| YTD | 126 584 | 72.8% | 2.0% | 0.9 | 60 331 491 | 127.6% | 1.9% | 1 | -3.9% |
| MAT | 625 118 | 31.8% | 1.6% | 0.5 | 274 764 553 | 72.9% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 75 344 | 26.8% | 12.7% | 1.6 | 158 886 968 | 19.1% | 9.3% | -0.3 | 10.5% |
| BRAINMAX | 19 157 | 119.8% | 100.0% | 0 | 67 073 937 | 113.6% | 100.0% | 0 | 119.8% |
| GOLDLINE PLUS | 138 972 | -2.9% | 45.2% | 1.4 | 450 972 800 | -2.5% | 37.0% | 0.9 | -6.0% |
| MIGRENIUM | 73 156 | -32.3% | 0.4% | -0.2 | 25 418 441 | -14.5% | 0.5% | -0.1 | 1.6% |
| MODELAX-N | 286 886 | 8.4% | 21.7% | 0 | 147 842 822 | 38.6% | 15.3% | 2.1 | 8.6% |
| REDUXIN CAPS | 98 761 | -9.5% | 32.1% | -1.3 | 539 166 826 | -8.5% | 44.2% | -1.8 | -6.0% |
| REDUXIN FORTE | 30 963 | 8.0% | 10.1% | 1.3 | 138 736 601 | 8.8% | 11.4% | 1.4 | -6.0% |
| SALVISAR | 126 584 | 72.8% | 2.0% | 0.9 | 60 331 491 | 127.6% | 1.9% | 1 | -3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 437 355 | 23.4% | 12.6% | 3.1 | 864 541 603 | 22.1% | 9.3% | 1.2 | -6.9% |
| BRAINMAX | 93 106 | 83.7% | 100.0% | 0 | 322 396 983 | 82.6% | 100.0% | 0 | 83.7% |
| GOLDLINE PLUS | 824 978 | -6.0% | 45.7% | 0.4 | 2 591 144 365 | -5.8% | 37.3% | -2.1 | -6.7% |
| MIGRENIUM | 532 895 | -17.2% | 0.5% | -0.1 | 177 343 379 | 33.1% | 0.6% | 0.1 | 0.5% |
| MODELAX-N | 1 485 807 | 17.1% | 21.7% | 2.2 | 700 432 373 | 60.4% | 14.5% | 3.5 | 5.0% |
| REDUXIN CAPS | 585 124 | -7.3% | 32.4% | -0.2 | 3 113 290 846 | 4.5% | 44.8% | 2.1 | -6.7% |
| REDUXIN FORTE | 169 662 | 0.5% | 9.4% | 0.7 | 732 870 956 | 6.8% | 10.6% | 0.7 | -6.7% |
| SALVISAR | 625 118 | 31.8% | 1.6% | 0.5 | 274 764 553 | 72.9% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 445 | -0.5% | 12.1% | -1.1 | 20 103 216 | -2.5% | 8.8% | -1 | 8.2% |
| BRAINMAX | 2 536 | 8.6% | 100.0% | 0 | 8 461 772 | 4.7% | 100.0% | 0 | 8.6% |
| GOLDLINE PLUS | 16 643 | 3.9% | 45.1% | -0.3 | 53 794 468 | 4.8% | 36.3% | 0 | 4.6% |
| MIGRENIUM | 8 723 | 5.6% | 0.4% | 0 | 3 070 253 | 7.6% | 0.5% | 0 | 4.8% |
| MODELAX-N | 33 001 | -2.7% | 20.9% | -1.2 | 17 228 201 | -1.8% | 15.1% | -0.6 | 2.7% |
| REDUXIN CAPS | 12 118 | 6.5% | 32.9% | 0.6 | 67 336 377 | 4.9% | 45.4% | 0 | 4.6% |
| REDUXIN FORTE | 3 857 | 8.7% | 10.5% | 0.4 | 17 305 807 | 8.5% | 11.7% | 0.4 | 4.6% |
| SALVISAR | 14 498 | -6.8% | 1.9% | -0.2 | 7 086 647 | -5.4% | 1.9% | -0.2 | 2.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| BRAINMAX | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| GOLDLINE PLUS | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| MIGRENIUM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| MODELAX-N | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| REDUXIN CAPS | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| REDUXIN FORTE | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| SALVISAR | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs